Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma (Q33401755)

26 July 2017

Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma (English)

1 reference

26 July 2017

0 references

0 references

1 reference

Christopher A Barker

1

0 references

author name string

Maria Chang

2

1 reference

26 July 2017

Joanne F Chou

3

1 reference

26 July 2017

Zhigang Zhang

4

1 reference

26 July 2017

Kathryn Beal

5

1 reference

26 July 2017

Philip H Gutin

6

1 reference

26 July 2017

Fabio M Iwamoto

7

1 reference

26 July 2017

12 June 2012

1 reference

Journal of Neuro-Oncology

26 July 2017

1 reference

26 July 2017

109

1 reference

26 July 2017

2

1 reference

26 July 2017

391-397

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-012-0906-4

26 July 2017

0 references

cites work

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4712045

In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4712045

The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4712045

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4712045

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4712045

Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4712045

In vitro evaluation of temozolomide combined with X-irradiation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4712045

The linear-quadratic formula and progress in fractionated radiotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4712045

Patterns of care in elderly glioblastoma patients

21 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

Debulking or biopsy of malignant glioma in elderly people - a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

Radiotherapy for glioblastoma in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

A randomized trial comparing 35Gy in ten fractions with 60Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

Glioblastoma in elderly patients: safety and efficacy of adjuvant radiotherapy with concomitant temozolomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

Glioblastoma multiforme in the elderly: a therapeutic challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

An estimation of radiobiologic parameters from clinical outcomes for radiation treatment planning of brain tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

Age influences chemotherapy response in astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0906-4

Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4712045

10.1007/S11060-012-0906-4

31 October 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference